Advertisement

Advertisement

SXTP Stock Latest News

Interim Trial Plan Finalized for Tafenoquine Babesiosis Study

Company AnnouncementsInterim Trial Plan Finalized for Tafenoquine Babesiosis Study

60 Degrees Pharmaceuticals signs option deal with Florida State University

PremiumThe Fly

60 Degrees Pharmaceuticals signs option deal with Florida State University

10d ago

60 Degrees Pharmaceuticals announces DSMB recommendation for B-Free study

PremiumThe Fly

60 Degrees Pharmaceuticals announces DSMB recommendation for B-Free study

17d ago

60 Degrees executes patent licensing agreement with Florida State

PremiumThe Fly

60 Degrees executes patent licensing agreement with Florida State

1M ago

60 Degrees details tafenoquine priority review voucher strategy

PremiumCompany Announcements

60 Degrees details tafenoquine priority review voucher strategy

1M ago

60 Degrees announces early enrollment of first patient in trial of tafenoquine

PremiumThe Fly60 Degrees announces early enrollment of first patient in trial of tafenoquine

2M ago

H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

The Fly

H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending

2M ago

60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

The Fly

60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

2M ago

60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

PremiumThe Fly

60 Degrees Pharmaceuticals reports Arakoda availability on Runway Health website

3M ago

SXTP Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

SXTP Earnings Report this Week: Is It a Buy, Ahead of Earnings?

4M ago

60 Degrees Updates Affiliate Share Ownership Disclosure Error

PremiumCompany Announcements

60 Degrees Updates Affiliate Share Ownership Disclosure Error

4M ago

60 Degrees submits NDIN to FDA for Australian Chestnut Extract

PremiumThe Fly

60 Degrees submits NDIN to FDA for Australian Chestnut Extract

4M ago

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

PremiumCompany Announcements60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

4M ago

60 Degrees Pharmaceuticals Updates Opinion for ATM Program

Company Announcements

60 Degrees Pharmaceuticals Updates Opinion for ATM Program

4M ago

60 Degrees reports all patients cured of babesiosis after tafenoquine treatment

The Fly

60 Degrees reports all patients cured of babesiosis after tafenoquine treatment

4M ago

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

PremiumCompany Announcements

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

5M ago

60 Degrees expands access to Arakoda with GoodRx partnership

PremiumThe Fly

60 Degrees expands access to Arakoda with GoodRx partnership

6M ago

60 Degrees Pharmaceuticals to exercise option in agreement with FSU

PremiumThe Fly

60 Degrees Pharmaceuticals to exercise option in agreement with FSU

6M ago

Runway Health Partnership and Multi-Pronged Commercial Strategy Underpin Buy Rating on 60 Degrees Pharmaceuticals

PremiumRatings

Runway Health Partnership and Multi-Pronged Commercial Strategy Underpin Buy Rating on 60 Degrees Pharmaceuticals

6M ago

60 Degrees Pharmaceuticals target adjusted to $24 at H.C. Wainwright after split

PremiumThe Fly60 Degrees Pharmaceuticals target adjusted to $24 at H.C. Wainwright after split

6M ago

60 Degrees Pharmaceuticals Faces Immediate Nasdaq Delisting Appeal

Company Announcements

60 Degrees Pharmaceuticals Faces Immediate Nasdaq Delisting Appeal

6M ago

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

Market News

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >